Anti-inflammatory drugs for depression: new review points to benefits, but more research needed

shutterstock_95463775

Helge Hasselmann highlights a recent systematic review of anti-inflammatory drugs for depression, which concludes that NSAIDs, in particular celecoxib, decreases depressive symptoms without increased risk of adverse effects. However, the meta-analysis has a number of draw-backs, which make the study findings far from convincing.

[read the full story...]